Lixte Biotechnology (LIXT) had the highest return on February 7, 2023 by a US stock, returning 136.3%.

ASSET	DATE	% RETURN
Lixte Biotechnology (LIXT)	2/7/2023	136.25%
Lixte Biotechnology (LIXTW)	2/7/2023	134.23%
Abpro (ABPWW)	2/7/2023	89.13%
Mobilicom Limited Warrants (MOBBW)	2/7/2023	65.12%
AEye (LIDRW)	2/7/2023	53.61%
Sol Strategies Inc Common Shares (STKE)	2/7/2023	46.81%
Moolec Science SA Warrant (MLECW)	2/7/2023	44.81%
American Rebel Holdings Inc Warrants (AREBW)	2/7/2023	44.22%
iBio, Inc Common Stock (IBIO)	2/7/2023	44.21%
Selectquote (SLQT)	2/7/2023	41.35%
Cardio Diagnostics (CDIO)	2/7/2023	40.12%
TOMI Environmental Solutions (TOMZ)	2/7/2023	35.53%
Bit Origin (BTOG)	2/7/2023	33.33%
Firefly Neuroscience (AIFF)	2/7/2023	32.31%
Ainos (AIMDW)	2/7/2023	31.94%
Scilex (SCLXW)	2/7/2023	30.78%
Next Technology (NXTT)	2/7/2023	28.93%
NeuroSense Therapeutics Ltd Warrant (NRSNW)	2/7/2023	27.25%
Quhuo (QH)	2/7/2023	27.03%
Zhihu Inc ADR (ZH)	2/7/2023	26.35%
Galectin Therapeutics (GALT)	2/7/2023	24.5%
Iveda Solutions (IVDA)	2/7/2023	24.26%
Lottery, Inc Warrants (LTRYW)	2/7/2023	23.78%
Versus Systems Inc. (VS)	2/7/2023	23.15%
Sidus Space (SIDU)	2/7/2023	21.77%